Chenodeoxycholic Acid Test

Chenodeoxycholic acid, often shortened to CDCA, is one of the body’s primary bile acids, molecules made in the liver from cholesterol. Its original and most obvious role is to help you digest and absorb dietary fats. To make this possible, the liver converts cholesterol into CDCA, attaches it to amino acids such as glycine or taurine to improve solubility, and releases it into bile. Once bile enters the intestine, CDCA acts like a detergent, breaking down large fat droplets into smaller ones so enzymes can work more efficiently.

But CDCA’s influence goes far beyond digestion. It functions as a signaling molecule, meaning it communicates with specific receptors in your cells to regulate metabolism and immunity. Two of the most important receptors it activates are:

• Farnesoid X receptor (FXR): A nuclear receptor inside cells that helps control cholesterol, triglyceride, and glucose levels. By signaling through FXR, CDCA helps keep lipid and sugar metabolism in balance and reduces unnecessary bile acid production.
• G protein-coupled bile acid receptor 1 (GPBAR1, also called TGR5): A receptor found on cell surfaces that helps regulate energy use, insulin sensitivity, and inflammation.

Through these pathways, CDCA influences blood sugar control, liver fat accumulation, and inflammatory responses. Research shows that disrupted CDCA signaling may play a role in non-alcoholic fatty liver disease (NAFLD) and other metabolic disorders.

Gut bacteria also shape CDCA’s activity. When CDCA enters the intestine, microbes can convert it into secondary bile acids such as lithocholic acid. This transformation not only changes how bile acids interact with our body but also reflects the two-way relationship between host metabolism and the gut microbiome. An imbalance here can contribute to liver disease, metabolic dysfunction, or altered immune responses.